Key words: glycine --glutaraldehyde --specificity --affinity --immunocytochemistry --brainstem --spinal cord Antibodies were raised against glycine and they were specific for immunocytochemistry. Obtained from rabbits immunized with glycine conjugated to glutaryled protein-carriers, antisera were then purified by adsorption on the various glutaraldehyde-conjugated protein-carriers. Using a modified ELISA method, their specificity was determined in competition experiments between conjugated glycine and either non-conjugated glycine or other conjugated amino acids or derivatives, preincubated with anti-glycine antibodies. Calculated at half-displacement, the resulting cross-reactivity ratios showed conjugated glycine to be the best recognized compound. By revealing the presence of the majority of the glycine-containing cell bodies in the brainstem and spinal cord, immunocytochemical applications of glycine antibodies confirmed their use as specific tools for a better understanding of the role of glycine in the central nervous system.
From neurophysiological studies 5'~9 it has been suggested that glycine, an amino acid, could function as a major inhibitory neurotransmitter in the central nervous system of mammals. More precisely, glycine was observed to behave very much like the natural inhibitory transmitter in the spinal cord and in several regions of rat brain s. By using brain slices or synaptosomal preparations, some authors have observed a depolarization-induced release of glycine from central nervous tissues as well as high levels of glycine in the spinal cord, suggesting it may have a function for spinal interneurons 2. Other investigations performed upon the uptake of [3H]glycine in rat central nervous system slices and homogenates, coupled or not with autoradiography, have contributed to support the idea that glycine was an important inhibitory substance 9A°'12'13"15-17. The characterization of the glycine receptor has reinforced the physiological action of glycine as an inhibitory neurotransmitter ~4'15.
However, glycine was neither demonstrated directly nor specifically because it is difficult to raise specific antibodies against small-sized haptens. The development of antibodies against other amino acid transmitters and their derivatives encouraged us to attempt to obtain antibodies to glycine, using experimental conditions similar to those previously described for small neurotransmitter-like molecules3,n,6,7A 8.
The present report describes the results of our studies, including the characterization of glycine antibodies as well as their utilization for immunocytochemically localizing glycine in rat brain.
To make it immunogenic, glycine (Gly, Merck) was conjugated to protein-carriers treated with glutaraldehyde 3'4. Gly (5 mg) was dissolved in 1 ml of a 1.5 M acetate solution, pH 8. The pH was adjusted to 7.6. Twokd of [3H]Gly (2.26 x 10 -5 M, spec. act. 44.2 Ci/mmol, NEN) was added in order to control each step of the immunological procedure. Then, 500 kd of a 0.5 M glutaraldehyde solution (Merck) was added for 5 min. The mixture containing activated Gly was rapidly mixed with 1 ml of a 1.5 M acetate solution, pH 8, containing 15 mg of either bovine serum albumin (BSA, Sigma), or human serum albumin (HSA,
